← Eichor
Study identifier: NCT06410274 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Ischaemic Lesions in Acute Intracerebral Haemorrhage

Condition: Intracerebral Haemorrhage  ·  Sponsor: University of Leicester

PhaseN/A
Planned participants120
Who can joinAll sexes, 18 Years to 120 Years
Healthy volunteersNo

About this study

The aim of this observational study is to determine how and why inadequate brain blood flow occurs after bleeding in patients with intracerebral haemorrhage (ICH). Treatment for strokes caused by burst blood vessels involves reducing blood pressure (BP) to stop the bleeding. However, this reduction in BP may affect blood flow, causing blockages in blood vessels within the brain. Fast breathing also affects brain blood flow. Therefore, participants will be asked to undergo a simple brain blood flow assessment using transcranial Doppler (TCD) within 48 hours upon admission to hospital. Patients will then have a follow-up TCD assessment at 4-7 days post-ICH onset, in addition to an MRI scan at \>7 days. This research will help to confirm if blockages after bleeding are caused by reduced blood flow within the brain.

This description comes directly from the study's public registry record.

Talk to the study team

Jatinder Minhas, SFHEA  ·  +44 116 252 3299  ·  jm591@leicester.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospitals of Leicester NHS TrustLeicester, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06410274